Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_2
1
14%
Ph phase_1
1
14%
Ph not_applicable
3
43%
Ph phase_3
1
14%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(2)
Terminated(1)
Other(4)

Detailed Status

unknown4
Completed2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
66.7%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (16.7%)
Phase 21 (16.7%)
Phase 31 (16.7%)
N/A3 (50.0%)

Trials by Status

terminated114%
completed229%
unknown457%

Recent Activity

0 active trials
Showing 5 of 7
terminatedphase_2

FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer

NCT02485834
unknown

Real-world Study on Comprehensive Treatment of Esophageal Cancer Based on Precision Radiotherapy

NCT05543057
completedphase_1

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

NCT00002602
unknownnot_applicable

Study of Tomotherapy HD in Medulloblastoma

NCT03675230
unknownphase_3

3DCRT vs. IMRT in Early Breast Cancer

NCT02440191
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT02485834Phase 2

FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer

Terminated
NCT05543057

Real-world Study on Comprehensive Treatment of Esophageal Cancer Based on Precision Radiotherapy

Unknown
NCT00002602Phase 1

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Completed
NCT03675230Not Applicable

Study of Tomotherapy HD in Medulloblastoma

Unknown
NCT02440191Phase 3

3DCRT vs. IMRT in Early Breast Cancer

Unknown
NCT02724475Not Applicable

Laser Ablation for Intermediate and Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Completed
NCT01201044Not Applicable

Study to Investigate Bronchial Arterrial Infusing (BAI) Plus Three-dimensional Conformal Radiotherapy (3DCRT) in Local Advanced Non-small Cell Lung Cancer (NSCLC)

Unknown

All 7 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
7